| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.60B | — | +58.9% |
| R&D Expense | $46.0M | — | -74.7% |
| SG&A Expense | $97.0M | — | -7.6% |
| Operating Income | $1.15B | — | +6.6% |
| Pre-tax Income | $736.0M | — | +10.2% |
| Income Tax | $111.0M | — | -26.5% |
| Net Income | $625.0M | — | +20.9% |
| EPS (Basic) | $0.20 | — | +17.6% |
| EPS (Diluted) | $0.19 | — | +26.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.60B | -32.1% | -55.6% |
| Accounts Receivable | $810.0M | -11.8% | +26.6% |
| Inventory | $241.0M | -4.7% | +27.5% |
| Current Assets | $3.22B | -20.3% | -34.2% |
| Total Assets | $56.30B | +5.3% | +25.0% |
| Current Liabilities | $3.71B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $763.0M | — | -31.5% |
| Capital Expenditures | $3.18B | — | -8.2% |
| Investing Cash Flow | -$3.00B | — | +13.6% |
| Financing Cash Flow | $1.86B | — | +4.8% |
| Free Cash Flow | -$2.42B | — | -2.8% |
| +31.4% |
| Long-term Debt | $36.58B | +6.9% | +24.8% |
| Total Liabilities | $43.95B | +6.0% | +25.1% |
| Stockholders' Equity | $7.23B | +7.3% | +48.2% |